The HER2 space continues to storm ahead of other oncology fields due to the overwhelming success of Enhertu and the continued satisfaction with Herceptin. As we enter 2023, the...

This Fall, the world's longest-standing and most comprehensive TPD meeting, the 6th TPD Summit, returns to Boston in 2023 as the trusted, definitive, end-to-end forum for the...

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm...